Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Immunotec Announces New CEO

Published: Monday, May 20, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
Immunotec Inc. announced the appointment of Mr. Charles L. Orr as its Chief Executive Officer.

Mr. Orr has served since March 2009 as Executive Director of the Direct Selling Education Foundation, where he held ultimate responsibility for the Foundation's programs and activities. Since 2001, he has provided his proven and successful expertise by active participation as a board member and advisor in a variety of publicly traded and privately held organizations ranging from over a billion dollars in revenue to start-ups. Mr. Orr served as President and Chief Executive Officer of Shaklee Corporation (1993-2000), where he was responsible for the performance of the company's diverse business units. Shaklee, then a $700m revenue company, included the brand names of Harry and David, Jackson and Perkins, and Shaklee. Mr. Orr has been a director of Immunotec since 2006.

Mr. Orr is a seasoned professional with 23 years of experience in the direct selling field. Additionally, his work history includes extensive leadership responsibility in the financial services and computer industries. Mr. Orr was selected as Chief Executive Officer based on a track record leading complex organizations, as well as strong executive and personal qualities. Mr. Orr earned a BA in Psychology from Wesleyan University and an MBA from the University of Connecticut.

In 2005, Mr. Orr received the distinctive Circle of Honor Award from the Direct Selling Education Foundation. In 2007, he was honored by the Direct Selling Association with its prestigious Hall of Fame Award.

Mr. Orr will work out of the Corporation's offices in Vaudreuil, Quebec once all immigration approvals have been obtained.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!